Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OX9W
|
||||
| Former ID |
DCL000847
|
||||
| Drug Name |
Inolimomab
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Indication | Heart transplant rejection [ICD9: 996; ICD10:T86] | Phase 3 | [537129] | ||
| Company |
EUSA Pharma
|
||||
| CAS Number |
CAS 152981-31-2
|
||||
| SuperDrug ATC ID |
A11GA01
|
||||
| SuperDrug CAS ID |
cas=000050817
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-2 receptor alpha chain | Target Info | Modulator | ||
| PANTHER Pathway | Interleukin signaling pathway | ||||
| Pathway Interaction Database | IL12-mediated signaling events | ||||
| Calcineurin-regulated NFAT-dependent transcription in lymphocytes | |||||
| Arf6 trafficking events | |||||
| SHP2 signaling | |||||
| IL2-mediated signaling events | |||||
| IL2 signaling events mediated by PI3K | |||||
| IL2 signaling events mediated by STAT5 | |||||
| Calcium signaling in the CD4+ TCR pathway | |||||
| Downstream signaling in naï | |||||
| IL12 signaling mediated by STAT4 | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.